Key Finding
A randomized controlled pilot trial is underway to evaluate whether electroacupuncture combined with standard medication can address both tinnitus and hearing outcomes in patients with idiopathic sudden sensorineural hearing loss, an approach largely overlooked by current treatment protocols.
Could Electroacupuncture Help Relieve Tinnitus After Sudden Hearing Loss?
If you've ever experienced a ringing, buzzing, or hissing sound in your ears with no obvious source, you know how disruptive tinnitus can be. For people who develop tinnitus alongside sudden sensorineural hearing loss (SSNHL) — a rapid, unexplained loss of hearing — the experience can be especially distressing, triggering anxiety and significantly reducing quality of life.
Researchers in China are conducting a clinical trial to explore whether electroacupuncture (EA) — a form of acupuncture that applies gentle electrical stimulation through the needles — can help when added to standard medication treatment for this condition. The study is enrolling 60 patients who have been diagnosed with SSNHL accompanied by tinnitus. Half receive standard drug treatment alone, while the other half receive the same medication plus four weeks of electroacupuncture sessions.
What makes this study particularly meaningful is that most current treatments focus almost entirely on restoring hearing, often leaving tinnitus unaddressed. Electroacupuncture has been widely used in China for tinnitus management and may work by targeting both the auditory system and the psychological stress that so often accompanies persistent ear noise.
Researchers are tracking several outcomes: hearing test results, tinnitus severity scores, anxiety levels, speech recognition ability in noisy environments, and overall quality of life — measured at multiple points during and after the four-week treatment period.
This is a pilot trial, meaning its primary goal is to test whether this combined approach is practical and safe enough to justify a larger, more definitive study. Early enrollment is progressing well, with 42 participants already enrolled as of the study's reporting date.
Full results are expected to be published in 2026, but the early momentum is encouraging for those seeking non-drug options for tinnitus relief.
If you're interested in electroacupuncture for tinnitus or hearing-related concerns, seek care from a licensed acupuncturist with experience in auditory conditions.
This prospective, double-center, assessor-blinded RCT (ChiCTR2400086802) is evaluating electroacupuncture (EA) as an adjunctive therapy to standard pharmacological treatment in patients presenting with idiopathic sudden sensorineural hearing loss (ISSNHL) accompanied by tinnitus. Sixty patients are randomized 1:1 to EA plus medication or medication alone over a four-week treatment protocol, with follow-up assessments at 2 and 4 weeks and 1, 2, and 3 months post-treatment. Primary feasibility outcomes include recruitment rate, adherence, data completeness, and safety. Clinical efficacy outcomes encompass pure tone audiometry, tinnitus matching, and the Tinnitus Handicap Inventory (THI); secondary measures include speech-recognition thresholds in noise, the Self-Rating Anxiety Scale, and SF-36. To date, 42 participants are enrolled with 35 completing intervention. No effect size data are yet published. This pilot is designed to power future multicenter trials and addresses a significant gap in ISSNHL management — the concurrent treatment of tinnitus alongside hearing restoration.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Transcutaneous electrical stimulation at Zusanli (ST36) upregulated neurotrophic factors BDNF and NGF, while Neiguan (PC6) stimulation elevated NPY and sympathoadrenal markers, demonstrating distinct point-specific effects on neuroimmune modulation and postoperative pain outcomes in lumbar disc herniation surgery patients.
📌 Electroacupuncture at GV20, ST25, and BL25 reduced both visceral hypersensitivity and negative emotions in an IBS-D model by suppressing overactivated PVN CRFergic neurons and downregulating the downstream colonic CRF-R1/mast cell/TRPV1 inflammatory pathway.
📌 Electroacupuncture at ST 25 and ST 37 significantly reduced visceral hypersensitivity and anxiety-like behavior in IBS-D rats by downregulating colonic NGF, TrkA, and TRPV1 protein expression.